1. O’Brien E. Why ABPM should be mandatory in all trials of blood pressure-lowering drugs. Drug Inf J. 2011;45:233–239
2. Tribenzor. Highlights of prescribing information. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200175s001lbl.pdf.
3. Edarbi. Highlights of prescribing information. 2011. http://www.accessdata.fda.gov/drugsatfda _docs/label/2011/200796s001lbl.pdf.
4. Center for Drug Evaluation and Research. Valturna medical review. 2009. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022217s000medr.pdf.
5. Center for Drug Evaluation and Research. Tekturna medical review. 2007 http://wwwaccessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_MedR_Pl.pdf.